Charlotte Zerna

ORCID: 0000-0001-5969-8990
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Stroke Rehabilitation and Recovery
  • Venous Thromboembolism Diagnosis and Management
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Dementia and Cognitive Impairment Research
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Clinical practice guidelines implementation
  • Neurological Disease Mechanisms and Treatments
  • Peripheral Artery Disease Management
  • Neurological Disorders and Treatments
  • Neurological and metabolic disorders
  • Medical Imaging and Analysis
  • Healthcare Systems and Practices
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Intracranial Aneurysms: Treatment and Complications
  • Blood Pressure and Hypertension Studies
  • Advanced X-ray and CT Imaging
  • Cardiac Imaging and Diagnostics
  • Blood properties and coagulation
  • Cardiovascular and Diving-Related Complications
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Health, Environment, Cognitive Aging
  • Brain Metastases and Treatment
  • Neuroinflammation and Neurodegeneration Mechanisms

Städtisches Klinikum Dresden
2022-2025

University of Calgary
2015-2024

Foothills Medical Centre
2016-2021

Centre Hospitalier de l’Université de Montréal
2021

University of Toronto
2016-2020

Calgary Laboratory Services
2019-2020

Ontario Brain Institute
2019

Medanta The Medicity
2016-2018

Novartis (Canada)
2018

Laboratoire de Chimie
2018

Michael D. Hill Mayank Goyal Bijoy K. Menon Raul G. Nogueira Ryan McTaggart and 95 more Andrew M. Demchuk Alexandre Y. Poppe Brian Buck Thalia S. Field Dar Dowlatshahi Brian van Adel Richard H. Swartz Ruchir Shah Eric Sauvageau Charlotte Zerna Johanna M. Ospel Manish Joshi Mohammed Almekhlafi Karla J. Ryckborst Mark Lowerison Kathy Heard David Garman Diogo C Haussen Shawna M Cutting Shelagh B. Coutts Daniel Roy Jeremy Rempel Axel Rohr Daniela Iancu Demetrios J. Sahlas Amy Yu Thomas Devlin Ricardó A. Hanel Volker Puetz Frank L. Silver Bruce Campbell René Chapot Jeanne Teitelbaum Jennifer Mandzia Timothy Kleinig David Turkel‐Parrella Donald Heck Michael Kelly Aditya Bharatha Oh Young Bang Ashutosh P. Jadhav Rishi Gupta Donald Frei Jason Tarpley Cameron McDougall Staffan Holmin Joung‐Ho Rha Ajit S Puri Marie‐Christine Camden Götz Thomalla Hana Choe Stephen Phillips Joseph Schindler John Thornton Simon Nagel Ji Hoe Heo Sung‐Il Sohn Marios‐Nikos Psychogios Ronald F. Budzik Sidney Starkman Coleman Martin Paul Burns Seán Murphy George Α. Lopez Joey English Michael Tymianski Andrew M. Demchuk Philip A. Barber Eric E. Smith Simerpreet Bal Suresh Subramaniam Steven Peters P Couillard Gary Klein Peter K. Stys Bijoy K. Menon Shelagh B. Coutts Mohammed Almekhlafi Michael D. Hill Mayank Goyal John Wong Alim P. Mitha Muneer Eesa William Morrish Saad Alqatani Nima Kashani Manish Joshi Charlotte Zerna Johanna M. Ospel Prasanna Venkatesan Erika Teleg Amith Sitaram Brett Graham Stephen van Gaal Aimen Moussaddy

10.1016/s0140-6736(20)30258-0 article EN The Lancet 2020-02-21
Shelagh B. Coutts Sandeep Ankolekar Ramana Appireddy Juan F. Arenillas Zarina Assis and 95 more Peter Bailey Philip A. Barber Rodrigo Bazán Brian Buck Kenneth Butcher Marie‐Christine Camden Bruce Campbell Leanne K. Casaubon Luciana Catanese Kausik Chatterjee Philip Choi Brian Clarke Dar Dowlatshahi Julia Ferrari Thalia S. Field Aravind Ganesh Darshan Ghia Mayank Goyal Stefan Greisenegger Omid Halse MacKenzie Horn Gary Hunter Oje Imoukhuede Peter J. Kelly James Kennedy Carol Kenney Timothy Kleinig Kailash Krishnan Fabrício Oliveira Lima Jennifer Mandzia Martha Marko Sheila Cristina Ouriques Martins George Medvedev Bijoy K. Menon Sachin Mishra Carlos A. Molina Aimen Moussaddy Keith W. Muir Mark Parsons Andrew M W Penn Arthur Pille Octávio Marques Pontes‐Neto Christine Roffe Joaquı́n Serena Robert Simister Nishita Singh Neil J. Spratt Daniel Strbian Carol Huilian Tham M Ivan Wiggam David Williams M Willmot Teddy Y. Wu Amy Yu George Zachariah Atif Zafar Charlotte Zerna Michael D. Hill Marina Salluzzi Nicole Blenkin Ashley Dueck Craig Doram Qiao Zhang Carol Kenney Karla J. Ryckborst Shelly Bohn Quentin Collier Frances Taylor Brendan Cord Lethebe Anitha Jambula Kayla Sage Lana Toussaint Supryia Save Jaclyn Lee Nihay Laham-Karam Asfia Sultan Deepak Agrawal A Sitaram Andrew M. Demchuk Andrew Lockey A. Micielli Ankur Wadhwa Babawale Arabambi B Graham Chrysi Bogiatzi Darshan Doshi Debabrata Chakraborty Diana Kim Denise Vasquez D Singh Dominic Tse Earl C. Harrison Eric E. Smith Erika Teleg Evgenia Klourfeld

10.1016/s0140-6736(24)00921-8 article EN The Lancet 2024-05-17

Autopsy studies suggest that cerebral amyloid angiopathy (CAA) is associated with cognitive impairment and risk for dementia. We analyzed neuropsychological test data from a prospective cohort study of patients CAA to identify the prevalence its associations brain magnetic resonance imaging features apolipoprotein E genotype.Data were 34 CAA, 16 Alzheimer's disease, 69 mild impairment, 27 ischemic stroke participants. Neuropsychological results expressed as z scores in relation normative...

10.1161/strokeaha.116.012999 article EN Stroke 2016-06-24
Amy Yu Shabnam Vatanpour Aravind Ganesh Thalia S. Field Philip A. Barber and 95 more Philip Choi Brian Buck Timothy Kleinig Carlos A. Molina Bruce Campbell Ramana Appireddy Keith W. Muir Michael D. Hill Shelagh B. Coutts Marina Salluzzi Nicole Blenkin Ashley Dueck Craig Doram Qiao Zhang Carol Kenney Charlotte Zerna Karla J. Ryckborst Shelly Bohn Philip A. Barber Thalia S. Field Dar Dowlatshahi Robert J. Hard David M. Kent Renee Martin William Whiteley Quinten Collier Frances Taylor Brendan Cord Lethebe PA Barber C Kenney Anitha Jambula Karen Sage Karla J. Ryckborst Loren Toussaint Sushma Save Jungwha Lee Nihay Laham-Karam Assem A. Sultan Aimen Moussaddy Akshay Deepak A Sitaram Amy Yu Andrew M. Demchuk Andrew Lockey A. Micielli Ankur Wadhwa Aravind Ganesh Babawale Arabambi Bijoy K. Menon B Graham Clement C. Tham Charlotte Zerna Chrysi Bogiatzi Dolar Doshi Debabrata Chakraborty Do Young ‍Kim Denise Vasquez D Singh Darren Tse Earl C. Harrison Eric E. Smith Erika Teleg Evgenia Klourfeld Gary Klein Ivy Anne Sebastian J. Grimley Evans Janka Hegedus Julie Kromm Katie Lin Katrina Hannah D. Ignacio Khosrow Ghavami Mohammed Ismail Margaret Moores Marie-Andrée Panzini Martha Marko Matthew Boyko Michael D. Hill Mohammed Almekhlafi Nancy Newcommon Nicholar Maraj Nishita Singh Oje Imoukhuede Ondřej Volný Peter K. Stys Philip A. Barber P Couillard Piyush Ojha PrasannaVenkatesan Eswaradass RA Joundi Ramana Appireddy Rajesh Kumar Singh R.M. Asuncion Ryan T. Muir Subhalaxmi Dey Sana Mansoor

Background In this subanalysis of the TEMPO‐2 (Tenecteplase Versus Standard Care for Minor Ischaemic Stroke With Proven Occlusion) trial, a randomized clinical trial comparing tenecteplase and nonthrombolytic control in patients with minor stroke symptomatic intracranial occlusion, we investigated sex differences efficacy safety tenecteplase. Methods We compared outcomes after versus control, stratified by sex. also female male treated The primary outcome was “responder” outcome, defined as...

10.1161/jaha.124.039154 article EN cc-by-nc-nd Journal of the American Heart Association 2025-04-16

To evaluate whether the use of multiphase CT angiography (CTA) improves interrater agreement for intracranial occlusion detection between stroke neurology trainees and an expert neuroradiologist.A neuroradiologist 2 fellows independently reviewed 100 prospectively collected single-phase CTA scans from acute ischemic patients with mild symptoms (NIH Stroke Scale score ≤5). The presence location a vascular occlusion(s) were documented. Interrater single- was quantified using unweighted κ...

10.1212/wnl.0000000000002951 article EN Neurology 2016-07-07

The effectiveness of specific systems changes to reduce DTN (door-to-needle) time has not been fully evaluated. We analyzed the impact 4 reduction strategies implemented prospectively in a staggered fashion.The HASTE (Hurry Acute Stroke Treatment and Evaluation) project was 3 phases at single academic medical center. In I (June 6, 2012 June 5, 2013), baseline performance analyzed. II 2013 January 24, 2015), were implemented: (1) STAT stroke protocol prenotify team about incoming patients;...

10.1161/circoutcomes.116.003242 article EN Circulation Cardiovascular Quality and Outcomes 2017-01-01

Sex differences have been described in the presentation, care, and outcomes among people with acute ischemic strokes, but these are less understood for minor cerebrovascular events. The present study hypothesized that, compared men, women more likely to report nonfocal symptoms receive a stroke mimic diagnosis.To evaluate sex symptoms, diagnoses, of patients transient or neurologic events.This prospective cohort events mimics enrolled at multicenter academic emergency departments Canada...

10.1001/jamaneurol.2019.1305 article EN JAMA Neurology 2019-05-22

Background Five randomized controlled trials recently demonstrated efficacy of endovascular treatment in acute ischemic stroke. Telestroke networks can improve stroke care rural areas but their role patients undergoing is unknown. Aim We compared clinical outcomes between anterior circulation transferred after teleconsultation and those directly admitted to a tertiary center. Methods Data derived from consecutive with intracranial large vessel occlusion who underwent January 2010 December...

10.1177/1747493016681018 article EN International Journal of Stroke 2016-11-30

Background and Purpose— White matter lesions (WML) are associated with cognitive decline, increased stroke risk, disability in old age. We hypothesized that superimposed acute cerebrovascular occlusion on chronic preexisting injury (leukoaraiosis) leads to worse outcome after minor event, both using quantitative (volumetric) qualitative (Fazekas scale) assessment, as well relative total brain volume. Methods— WML volume assessment was performed 425 patients high-risk transient ischemic...

10.1161/strokeaha.117.017429 article EN Stroke 2018-03-14

To undertake an effectiveness and safety analysis of EVT in patients with LVO NIH Stroke Scale (NIHSS) score ≤6 using datasets multicenter multinational nature.We pooled anterior circulation occlusion from 3 prospective international cohorts. Patients were eligible if presentation occurred within 12 hours last known well baseline NIHSS ≤6. Primary outcome was modified Rankin (mRS) 0-1 at 90 days. Secondary outcomes included neurologic deterioration 24 (change ≥2 points), mRS 0-2 days, 90-day...

10.1212/wnl.0000000000010955 article EN Neurology 2020-09-29

<h3>BACKGROUND AND PURPOSE:</h3> Infarct volume is an important predictor of clinical outcome in acute stroke. We hypothesized that the association infarct and changes with magnitude size. <h3>MATERIALS METHODS:</h3> Data were derived from Safety Efficacy Nerinetide Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1) trial, which patients stroke large-vessel occlusion randomized to endovascular treatment plus either nerinetide or a placebo. was manually segmented on 24-hour...

10.3174/ajnr.a7183 article EN cc-by American Journal of Neuroradiology 2021-06-24

Background Intracranial hemorrhage is a known complication after endovascular treatment in patients with acute ischemic stroke due to large vessel occlusion, but the association between radiologic severity and outcome controversial. Purpose To investigate prevalence impact on of intracranial treatment. Materials Methods The Efficacy Safety Nerinetide for Treatment Acute Ischemic Stroke (ESCAPE-NA1) trial enrolled participants occlusion who underwent from March 1, 2017, August 12, 2019....

10.1148/radiol.2021204560 article EN Radiology 2021-06-01

Background The effect of infarct pattern on functional outcome in acute ischemic stroke is incompletely understood. Purpose To investigate the association qualitative and quantitative variables at 24-hour follow-up noncontrast CT diffusion-weighted MRI with 90-day clinical outcome. Materials Methods Safety Efficacy Nerinetide Subjects Undergoing Endovascular Thrombectomy for Stroke, or ESCAPE-NA1, randomized controlled trial enrolled patients large-vessel-occlusion undergoing mechanical...

10.1148/radiol.2021203964 article EN Radiology 2021-05-11

Respiratory infection can be an immediate precursor to stroke and myocardial infarction. Influenza vaccination is associated with reduced risk of infarction hospitalisation for cardiac disease, influenza strongly recommended patients heart disease. Evidence on whether the same protective association exists stroke, this potential effect consistent across age groups, conflicting. We aimed assess after in adults.We obtained administrative data from Alberta Health Care Insurance Plan (which...

10.1016/s2468-2667(22)00222-5 article EN cc-by-nc-nd The Lancet Public Health 2022-11-01

The effectiveness and safety of intravenous alteplase given before or concurrently with endovascular thrombectomy (EVT) is uncertain. Randomized clinical trials suggest there little difference in outcomes but only modest precision insufficient power to analyze uncommon including symptomatic intracranial hemorrhage (sICH).To determine whether 8 prespecified are different patients acute ischemic stroke treated routine practice EVT compared alone without alteplase. It was hypothesized that...

10.1001/jamaneurol.2022.1413 article EN JAMA Neurology 2022-06-13

Background and Purpose: To compare the benefit of endovascular treatment (EVT) in acute ischemic stroke (AIS) patients with large vessel occlusion (LVO) presenting &gt;6 hours from last known well outside a clinical trial setting to best medical management EVT randomized setting. Methods: Data retrospective multicenter cohort study (ESCAPE LATE) AIS-LVO treated beyond 6 at former ESCAPE sites were pooled historical data late time window patients. Unadjusted adjusted 90-day modified Rankin...

10.1161/str.56.suppl_1.wp259 article EN Stroke 2025-01-30

In the ESCAPE-NA1 (Efficacy and Safety of Nerinetide for Treatment Acute Ischaemic Stroke) trial, treatment with nerinetide was associated improved outcomes in patients who did not receive intravenous alteplase. We compared effect on clinical without concurrent alteplase within different patient subgroups. a multicenter randomized trial which acute stroke baseline Alberta Stroke Program Early CT Score (ASPECTS) >4 undergoing endovascular (EVT) were to or placebo. The primary outcome...

10.5853/jos.2024.03139 article EN cc-by-nc Journal of Stroke 2025-01-31
Coming Soon ...